Compare Organon Pharma Indonesia Tbk. (SCPI) vs Xolare RCR Energy Tbk. (SOLA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Xolare RCR Energy Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Xolare RCR Energy Tbk. trades at Rp91 (market cap 305.73B, 5.23M 24h volume). The key difference: Xolare RCR Energy Tbk. is far larger — about 2.9× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | SOLA | |
|---|---|---|
Market Cap | 104.4B | 305.73B |
Volume | — | 5.23M |
Lot | — | 52.32K |
Turnover | — | 472.84M |
Average Price | — | 90.37 |
Value | — | 472.84M |
Indicative Equilibrium Price | — | 91 |
Indicative Equilibrium Volume | — | 942 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Xolare RCR Energy Tbk.
PT Xolare RCR Energy (Formerly: PT RCR Energy Indonesia) (the "Company") was established based on Notarial Deed No. 213 dated December 18, 2014 drawn up before Notary Humberg Lie, S.H., S.E., M.Kn., in Jakarta. The ultimate beneficial owner of the Company is PT Energi Hijau Investama. The Company started its commercial activities in 2015.
Read more on SOLA →
